Fludarabine
Fludarabine
Fludarabine (pronounced /fluːˈdærəbiːn/) is a chemotherapy medication used to treat hematological malignancies such as chronic lymphocytic leukemia (CLL), non-Hodgkin lymphoma, and acute myeloid leukemia (AML). It is a purine analog, which interferes with DNA synthesis and repair.
Etymology
The term "Fludarabine" is derived from the compound's chemical structure, which is a fluorinated derivative of the nucleoside analog vidarabine.
Usage
Fludarabine is primarily used in the treatment of chronic lymphocytic leukemia, non-Hodgkin lymphoma, and acute myeloid leukemia. It is often used in combination with other chemotherapy medications.
Mechanism of Action
Fludarabine is a purine analog, which means it mimics the structure of purine bases, the building blocks of DNA. Once inside the cell, fludarabine is converted into its active form, fludarabine triphosphate. This active form interferes with DNA synthesis and repair, leading to cell death.
Side Effects
Common side effects of fludarabine include nausea, vomiting, and myelosuppression. More serious side effects can include neurotoxicity and pulmonary toxicity.
Related Terms
External links
- Medical encyclopedia article on Fludarabine
- Wikipedia's article - Fludarabine
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski